- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: Docetaxel
Total 2012 results
-
NCT06060587Not yet recruiting
-
NCT06057610Not yet recruitingHER2-PositiveRecurrent or Metastatic Breast Cancer
-
NCT06046482Not yet recruitingSquamous Cell Carcinoma of Head and Neck | Head Neck
-
NCT06042569RecruitingAnatomic Stage I Breast Cancer AJCC v8 | Anatomic Stage II Breast Cancer AJCC v8 | Anatomic Stage III Breast Cancer AJCC v8 | HER2-Negative Breast Carcinoma
-
NCT06038539Not yet recruitingHR Negative HER2 Positive Early Breast Cancer or Locally Advanced Breast Cancer Patients
-
NCT06028737RecruitingStomach Cancer | Gastric Cancer | Gastric Adenocarcinoma | Gastrointestinal Cancer | Gastroesophageal Junction Adenocarcinoma | Advanced Gastric Adenocarcinoma | GastroEsophageal Cancer | Stomach Neoplasm | Gastric Neoplasm | Advanced Gastric Carcinoma
-
NCT06029127Not yet recruiting
-
NCT06023875RecruitingHead and Neck Squamous Cell Carcinoma | Locally Advanced Operable
-
NCT06012435Not yet recruitingCarcinoma, Non-Small-Cell Lung
-
NCT06009627Recruiting
-
NCT05999994Recruiting
-
NCT05983783RecruitingChemotherapy Effect | Metastatic Prostate Cancer | Hormone Sensitive Prostate Cancer
-
NCT05978648Not yet recruiting
-
NCT05960955Not yet recruitingResectable Gastric or Gastroesophageal Junction Adenocarcinoma
-
NCT05943795RecruitingSquamous Cell Carcinoma of Lung | Non-small Cell Lung Adenocarcinoma
-
NCT05929768RecruitingAnatomic Stage I Breast Cancer AJCC v8 | Anatomic Stage II Breast Cancer AJCC v8 | Anatomic Stage IIIA Breast Cancer AJCC v8 | Anatomic Stage IIIB Breast Cancer AJCC v8 | Early Stage Triple-Negative Breast Carcinoma
-
NCT05919537RecruitingPancreatic Cancer | Non-Small Cell Lung Cancer | Metastatic Solid Tumor | Locally Advanced Solid Tumor
-
NCT05914753Not yet recruitingBreast Cancer | Chemotherapy Effect
-
NCT05910827RecruitingAdvanced or Metastatic Squamous Non-Small Cell Lung Cancer
-
NCT05910034Not yet recruitingAdvanced Non-Small Cell Lung Cancer
-
NCT05904379RecruitingAdvanced Non-small-cell Lung Cancer
-
NCT05901428RecruitingHormone Receptor Positive HER-2 Negative Breast Cancer
-
NCT05900206Not yet recruiting
-
NCT05883852RecruitingHER2 Positive Early Breast Cancer
-
NCT05878028RecruitingNon-small Cell Lung Cancer
-
NCT05863325Not yet recruitingLocally Advanced or Metastatic Non-Small Cell Lung Cancer
-
NCT05848011RecruitingProstate Cancer Recurrent | Immunotherapy | Androgen-Independent Prostatic Cancer | Androgen-Resistant Prostatic Cancer | Hormone Refractory Prostatic Cancer | Immune Checkpoint Inhibitor | Androgen-Independent Prostatic Neoplasms | Androgen-Insensitive Prostatic Cance | Inhibitory Checkpoint Molecule
-
NCT05836584RecruitingGastric Adenocarcinoma | Gastric Carcinoma | Clinical Stage III Gastric Cancer AJCC v8 | Clinical Stage III Gastroesophageal Junction Adenocarcinoma AJCC v8 | Gastroesophageal Junction Adenocarcinoma | Clinical Stage I Gastric Cancer AJCC v8 | Clinical Stage II Gastric Cancer AJCC v8 | Clinical Stage IVA Gastric Cancer AJCC v8 | Clinical Stage II Gastroesophageal Junction Adenocarcinoma AJCC v8 | Clinical Stage IVA Gastroesophageal Junction Adenocarcinoma AJCC v8
-
NCT05838066Not yet recruitingFirst-line Treatment of HER2-positive Recurrent or Metastatic Breast Cancer
-
NCT05834348Not yet recruiting
-
NCT05816499RecruitingNSCLC Stage IV | NSCLC Stage IIIB | NSCLC Stage IIIC
-
NCT05813015RecruitingChemotherapy Effect | Locally Advanced Gastric Adenocarcinoma
-
NCT05800587RecruitingLung Cancer | Non Small Cell Lung Cancer | Small-cell Lung Cancer
-
NCT05800054RecruitingEsophageal Neoplasms | Adverse Drug Event
-
NCT05798793Not yet recruiting
-
NCT05777278Not yet recruitingNon-small Cell Lung Cancer
-
NCT05769725RecruitingSerplulimab,Gastric Cancer, Adjuvant Therapy
-
NCT05762536Not yet recruitingMetastatic Castration-resistant Prostate Cancer
-
NCT05754853RecruitingAdvanced or Metastatic Urothelium Cancer
-
NCT05753306RecruitingGastric Adenocarcinoma | Gastroesophageal Junction Adenocarcinoma | Metastatic Malignant Neoplasm in the Peritoneum
-
NCT05733689Not yet recruitingGastroesophageal Adenocarcinoma
-
NCT05733351RecruitingStage IVB Prostate Cancer AJCC v8 | Metastatic Prostate Adenocarcinoma | Castration-Sensitive Prostate Carcinoma
-
NCT05727410RecruitingHigh-grade Salivary Gland Carcinoma
-
NCT05726370Not yet recruitingHead and Neck Cancer | Head and Neck Squamous Cell Carcinoma | Recurrent Head and Neck Squamous Cell Carcinoma | Resectable Head and Neck Squamous Cell Carcinoma
-
NCT05720026RecruitingHER2-positive Breast Cancer
-
NCT05715931RecruitingHER2-positive Gastric Cancer | Adenocarcinoma of the Stomach | Adenocarcinoma of Esophagogastric Junction
-
NCT05714553RecruitingMelanoma | Renal Cell Carcinoma | Gastric Cancer | Non Small Cell Lung Cancer | Metastatic Cancer | Triple Negative Breast Cancer | Advanced Solid Tumor | Advanced Cancer | Head and Neck Squamous Cell Carcinoma | Endometrial Carcinoma
-
NCT05712356RecruitingHead and Neck Cancer | Esophageal Cancer | Cholangiocarcinoma | Intrahepatic Cholangiocarcinoma | Head and Neck Squamous Cell Carcinoma | Esophageal Squamous Cell Carcinoma | Gallbladder Carcinoma | Gallbladder Cancer | Extrahepatic Cholangiocarcinoma | Advanced Head and Neck Squamous Cell Carcinoma